✦ LIBER ✦

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

✍ Scribed by Katja Grasmäder; Petra Louise Verwohlt; Marcella Rietschel; Aleksandra Dragicevic; Matthias Müller; Christoph Hiemke; Nikolaus Freymann; Astrid Zobel; Wolfgang Maier; Marie Luise Rao

Publisher: Springer
Year: 2004
Tongue: English
Weight: 209 KB
Volume: 60
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-004-0766-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of polymorphism of the conversion o

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19)

✍ P. Sandwall; M.-W. Lo; B. Jonzon; P. Dalén; C. Furtek; M. Ritter; G. Alván; J. M 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 95 KB

Impact of theCYP2D6polymorphism on stead

Impact of theCYP2D6polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients

✍ Federica Varsaldi; Gianluca Miglio; Maria Gabriella Scordo; Marja-Liisa Dahl; La 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 141 KB

Polymorphisms of drug-metabolizing enzym

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population

✍ Elena A. Gaikovitch; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Jürgen Brockmö 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 233 KB

Eltrombopag, an oral thrombopoietin rece

Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis

✍ Julian Jenkins; Daphne Williams; Yanli Deng; David A. Collins; Valerie S. Kitche 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 301 KB

In vitro comparative inhibition profiles

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

✍ C. Transon; T. Leemann; P. Dayer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 343 KB

British Surgical Practice. Surgical Prog

British Surgical Practice. Surgical Progress 1958. Edited by SIR ERNEST ROCK CARLING, Ll.D., F.R.C.S., F.F.R., Honorary Consulting Surgeon, Westminster Hospital; and Sir James Paterson Ross, K.C.V.O., Ll.D., M.S., P.R.C.S., F.R.A.C.S., F.A.C.S., Surgeon and Director of Surgical Clinical Unit, St. Bartholomew'S Hospital, London. 9 3/4 × 6 1/2 In. Pp. 441 + X, With 98 Illustrations and Fully Indexed. 1958. London: Butterworth & Co. (Publishers) Ltd. 52S. 6D.

📂 Article 📅 1959 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views